News & Events
-
Public Calendar: November 7-11, 2011
This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.
| November 7-11, 2011 | |||||
| FDA Official and Title | Date | Location | Other FDA Participants | Non-FDA Participants | Subject |
|---|---|---|---|---|---|
| Margaret A. Hamburg, M.D., Commissioner of Food and Drugs | 11/7/11 | New York, NY | N/A | N/A | Remarks at FasterCures: “Priming the Pump: Filling the Therapeutic Pipeline” |
| Margaret A. Hamburg, M.D., Commissioner of Food and Drugs | 11/10/11 | Washington, DC | N/A | N/A | Remarks at 2011 Fourth Annual Conference on Clinical Cancer Research |
| John M. Taylor, III, J.D., Counselor to the Commissioner | 11/7/11-11/11/11 | N/A | N/A | N/A | No Significant Meetings |
| Deborah M. Autor, Esq., Deputy Commissioner for Global Regulatory Operations and Policy | 11/7/11-11/11/11 | N/A | N/A | N/A | No Significant Meetings |
| Dara A. Corrigan, Associate Commissioner for Regulatory Affairs | 11/7/11-11/11/11 | N/A | N/A | N/A | No Significant Meetings |
| Virginia Cox, Associate Commissioner for External Affairs | 11/7/11-11/11/11 | N/A | N/A | N/A | No Significant Meetings |
| Lawrence Deyton, M.S.P.H., M.D., Director, Center for Tobacco Products | 11/7/11-11/11/11 | N/A | N/A | N/A | No Significant Meetings |
| Elizabeth H. Dickinson, Esq., Acting Chief Counsel | 11/7/11-11/11/11 | N/A | N/A | N/A | No Significant Meetings |
| David Dorsey, J.D., Acting Associate Commissioner for Policy and Planning | 11/7/11-11/11/11 | N/A | N/A | N/A | No Significant Meetings |
| Bernadette Dunham, D.V.M., Ph.D., Director, Center for Veterinary Medicine | 11/8/11 | Washington, DC | N/A | N/A | Speech - CVM Overview at Animal Health Institute's Regulator Day |
| Jesse Goodman, M.D., M.P.H., Chief Scientist and Deputy Commissioner for Science and Public Health | 11/7/11-11/11/11 | N/A | N/A | N/A | No Significant Meetings |
| Michael M. Landa, Acting Director, Center for Food Safety and Applied Nutrition | 11/7/11-11/11/11 | N/A | N/A | N/A | No Significant Meetings |
| Caroline Lewis, Associate Commissioner for Operations | 11/7/11-11/11/11 | N/A | N/A | N/A | No Significant Meetings |
| Karen Midthun, M.D., Director, Center for Biologics Evaluation and Research | 11/7/11-11/11/11 | N/A | N/A | N/A | No Significant Meetings |
| Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health | 11/7/11- 11/11/11 | N/A | N/A | N/A | No Significant Meetings |
| William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research | 11/8/11-11/9/11 | Jefferson, AR | Several FDA staff | FDA Science Board Member: Lynn R. Goldman (George Washington University); John R. Bucher (National Toxicology Program); NCTR Science Advisory Board (SAB) members: Cynthia A. Afshari (Amgen, Inc.) (SAB Chair); John D. Baker (Johnson and Johnson PRD); Scott W. Burchiel (University of New Mexico Health Sciences Center); Diana Dow-Edwards (SUNY Downstate Medical Center); Ronald Hines (Medical College of Wisconsin); Paul B. Watkins (The Hamner-UNC Institute for Drug Safety Sciences); Heidi Moline (Union of Concerned Scientists) | Annual meeting of the NCTR Science Advisory Board |
| Stephen Spielberg, M.D., Ph.D., Deputy Commissioner for Medical Products & Tobacco | 11/8/11 | New York, NY | N/A | Lesa Mitchell (Ewing Marion Kauffman Foundation); Michael Beckloff (Beckloff Associates, Inc.); Regis B. Kelly (The California Institute for Quantitative Biosciences (QB3), University of California); Scott J. Weir (Institute for Advancing Medical Innovation, University of Kansas Cancer Center) | Partnering for Cures Panel: Streamlining Drug Repurposing and Approval |
| Stephen Spielberg, M.D., Ph.D., Deputy Commissioner for Medical Products & Tobacco | 11/9/11 | Boston, MA | N/A | N/A | Keynote Speech at Personalized Medicine Conference |
| Michael R. Taylor, J.D., Deputy Commissioner for Foods, Office of Foods | 11/10/11 | Washington, DC | Bill Hubbard | Scott Faber (Grocery Manufacturers Association); Joseph Levitt (Hogan Lovells) | Food Safety |
| Jill Hartzler Warner, J.D., Acting Associate Commissioner for Special Medical Programs | 11/7/11-11/11/11 | N/A | N/A | N/A | No Significant Meetings |
| Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research | 11/8/11 | Washington, DC | N/A | Jeffrey Drazen (New England Journal of Medicine); Gary Filerman (Atlas Health Foundation); Richard Murray (Merck & Co., Inc.); Ihor Rak (AstraZeneca) | Envisioning a Transformed Clinical Trials Enterprise in the U.S.: Establishing an Agenda for 2020 |
| Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research | 11/9/11 | Arlington, VA | N/A | Mark Harrington (Treatment Action Group); Carol Nyirenda (Treatment Advocacy and Literary Campaign) | Critical Path to TB Drug Regimens Workshop |
-
-
